Package 51224-009-10

Brand: cholestyramine light

Generic: cholestyramine
NDC Package

Package Facts

Identity

Package NDC 51224-009-10
Digits Only 5122400910
Product NDC 51224-009
Product ID 51224-009_fb8b0e9c-1750-4016-95c7-d7a49e09d463
Description

201.6 g in 1 CAN (51224-009-10)

Marketing

Marketing Status
Discontinued 2027-01-31
Brand cholestyramine light
Generic cholestyramine
Sample Package No

Linked Drug Pages (1)

Cholestyramine Light ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "fb8b0e9c-1750-4016-95c7-d7a49e09d463", "openfda": {"nui": ["N0000180292", "N0000175365"], "unii": ["4B33BGI082"], "rxcui": ["1801279"], "spl_set_id": ["eb85a2c8-cdc3-48bb-844d-e220ae3701a0"], "pharm_class_epc": ["Bile Acid Sequestrant [EPC]"], "pharm_class_moa": ["Bile-acid Binding Activity [MoA]"], "manufacturer_name": ["TAGI Pharma, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "201.6 g in 1 CAN (51224-009-10)", "package_ndc": "51224-009-10", "marketing_end_date": "20270131", "marketing_start_date": "20201112"}], "brand_name": "Cholestyramine Light", "product_id": "51224-009_fb8b0e9c-1750-4016-95c7-d7a49e09d463", "dosage_form": "POWDER, FOR SUSPENSION", "pharm_class": ["Bile Acid Sequestrant [EPC]", "Bile-acid Binding Activity [MoA]"], "product_ndc": "51224-009", "generic_name": "Cholestyramine", "labeler_name": "TAGI Pharma, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cholestyramine Light", "active_ingredients": [{"name": "CHOLESTYRAMINE", "strength": "4 g/4.8g"}], "application_number": "ANDA209599", "marketing_category": "ANDA", "marketing_end_date": "20270131", "marketing_start_date": "20201112"}